Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

Related Articles by Review for PubMed (Select 20014874)

1.

The cost and incidence of prescribing errors among privately insured HIV patients.

Hellinger FJ, Encinosa WE.

Pharmacoeconomics. 2010;28(1):23-34. doi: 10.2165/11313810-000000000-00000.

PMID:
20014874
2.

Tipranavir: PNU 140690, tipranivir.

[No authors listed]

Drugs R D. 2006;7(1):55-62. Review.

PMID:
16620137
3.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
4.

Atazanavir/ritonavir: a review of its use in HIV therapy.

von Hentig N.

Drugs Today (Barc). 2008 Feb;44(2):103-32. doi: 10.1358/dot.2008.44.2.1137107. Review.

PMID:
18389089
5.

Atazanavir: a review of its use in the management of HIV infection.

Swainston Harrison T, Scott LJ.

Drugs. 2005;65(16):2309-36. Review.

PMID:
16266202
6.

A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.

Pinheiro Edos S, Antunes OA, Fortunak JM.

Antiviral Res. 2008 Sep;79(3):143-65. doi: 10.1016/j.antiviral.2008.05.001. Epub 2008 Jun 2. Review.

PMID:
18571246
7.

Atazanavir for the treatment of human immunodeficiency virus infection.

Busti AJ, Hall RG, Margolis DM.

Pharmacotherapy. 2004 Dec;24(12):1732-47. Review.

PMID:
15585441
8.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
9.
10.

[Efficacy of atazanavir in treatment-naive patients].

Moreno S, Hernández B, Dronda F.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 17:9-13. doi: 10.1016/S0213-005X(08)76614-X. Review. Spanish.

PMID:
20116611
11.

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2009 Oct;27(8):491.

PMID:
19246124
12.

Current and future antiretroviral treatment options in paediatric HIV infection.

Giaquinto C, Morelli E, Fregonese F, Rampon O, Penazzato M, de Rossi A, D'Elia R.

Clin Drug Investig. 2008;28(6):375-97. Review.

PMID:
18479179
13.

Optimizing HIV treatment programs.

Bautista-Arredondo S, Martz TE, Wirtz VJ, Bertozzi SM.

Curr Opin HIV AIDS. 2010 May;5(3):232-6. doi: 10.1097/COH.0b013e32833860d3. Review.

PMID:
20539079
14.

When patients cannot take pills: antiretroviral drug formulations for managing adult HIV infection.

Nyberg CR, Patterson BY, Williams MM.

Top Antivir Med. 2011 Aug-Sep;19(3):126-31. Review.

15.

HIV clinical pharmacists--the US perspective.

Scott JD, Abernathy KA, Diaz-Linares M, Graham KK, Lee JC.

Farm Hosp. 2010 Nov-Dec;34(6):303-8. doi: 10.1016/j.farma.2010.07.001. Epub 2010 Jul 31. Review.

PMID:
20674431
16.

Antiretroviral and Medication Errors in Hospitalized HIV-Positive Patients.

Li EH, Foisy MM.

Ann Pharmacother. 2014 May 8;48(8):998-1010. [Epub ahead of print] Review.

PMID:
24811394
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk